- Home
- CVKD vs ADXN Comparison
CVKD vs ADXN Comparison
Compare CVKD & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- ADXN
- Stock Information
- Founded
- CVKD 2022
- ADXN 2002
- Country
- CVKD United States
- ADXN Switzerland
- Employees
- CVKD N/A
- ADXN N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CVKD Health Care
- ADXN Health Care
- Exchange
- CVKD Nasdaq
- ADXN Nasdaq
- Market Cap
- CVKD 17.1M
- ADXN 11.3M
- IPO Year
- CVKD 2023
- ADXN N/A
- Fundamental
- Price
- CVKD $15.24
- ADXN $10.30
- Analyst Decision
- CVKD Strong Buy
- ADXN Strong Buy
- Analyst Count
- CVKD 2
- ADXN 1
- Target Price
- CVKD $52.50
- ADXN $30.00
- AVG Volume (30 Days)
- CVKD 59.6K
- ADXN 22.8K
- Earning Date
- CVKD 11-08-2024
- ADXN 11-11-2024
- Dividend Yield
- CVKD N/A
- ADXN N/A
- EPS Growth
- CVKD N/A
- ADXN N/A
- EPS
- CVKD N/A
- ADXN 0.05
- Revenue
- CVKD N/A
- ADXN $960,641.00
- Revenue This Year
- CVKD N/A
- ADXN N/A
- Revenue Next Year
- CVKD N/A
- ADXN N/A
- P/E Ratio
- CVKD N/A
- ADXN $1.75
- Revenue Growth
- CVKD N/A
- ADXN N/A
- 52 Week Low
- CVKD $5.40
- ADXN $5.00
- 52 Week High
- CVKD $32.55
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- CVKD 60.90
- ADXN 54.08
- Support Level
- CVKD $11.19
- ADXN $10.04
- Resistance Level
- CVKD $15.93
- ADXN $10.81
- Average True Range (ATR)
- CVKD 1.36
- ADXN 0.59
- MACD
- CVKD 0.23
- ADXN 0.04
- Stochastic Oscillator
- CVKD 61.01
- ADXN 70.88
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.